XML 20 R5.htm IDEA: XBRL DOCUMENT v3.6.0.2
CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDER'S EQUITY - USD ($)
Convertible Series B Preferred Stock
Common Stock
Additional Paid-In Capital
Employee Advances
Treasury Stock
Accumulated Deficit
Total
Beginning Balance, Amount at Dec. 31, 2014 $ 452 $ 38,750 $ 29,966,040 $ (2,143) $ (3,419,715) $ (30,212,865) $ (3,629,481)
Beginning Balance, Shares at Dec. 31, 2014 451,879 38,749,595     1,179,212    
Stock-based compensation 320,366 320,366
Issuance of Series B preferred stock as payment-in-kind for dividend, Amount $ 32 298,886 298,918
Issuance of Series B preferred stock as payment-in-kind for dividend, Shares 31,633          
Contractual dividends on Series B convertible preferred stock (319,854) (319,854)
Warrants issued as debt discount in connection with notes payable 69,600 69,600
Issuance of common stock and warrants for cash, Amount
Issuance of common stock and warrants for cash, Shares          
Imputed value of services contributed            
Change in fair value of collateral securing employee advances 2,143 2,143
Cashless exercise of warrants into common stock, Amount   $ 94 (94)
Cashless exercise of warrants into common stock, Shares 94,779          
Debt discount related to repricing of warrants in connection with notes payable 1,800 1,800
Net loss           (626,682) (626,682)
Ending Balance, Amount at Dec. 31, 2015 $ 484 $ 38,844 30,656,598 $ (3,419,715) (31,159,401) (3,883,190)
Ending Balance, Shares at Dec. 31, 2015 483,512 38,844,374     1,179,212    
Stock-based compensation     327,202       327,202
Issuance of Series B preferred stock as payment-in-kind for dividend, Amount $ 33 319,820       319,853
Issuance of Series B preferred stock as payment-in-kind for dividend, Shares 33,847          
Contractual dividends on Series B convertible preferred stock           (342,233) (342,233)
Warrants issued as debt discount in connection with notes payable     15,500       15,500
Change in fair value of collateral securing employee advances            
Cashless exercise of warrants into common stock, Amount   $ 1,155 (1,155)      
Cashless exercise of warrants into common stock, Shares   1,155,179          
Exercise of stock options into common stock, Amount   $ 17 1,816       1,833
Exercise of stock options into common stock, Shares   16,666          
Cashless exercise of stock options into common stock, Amount   $ 1,492 (1,492)      
Cashless exercise of stock options into common stock, Shares   1,492,078          
Conversion of accounts payable into common stock, Amount   $ 2,254 696,340       698,594
Conversion of accounts payable into common stock, Shares   2,253,528          
Net loss           (1,408,203) (1,408,203)
Ending Balance, Amount at Dec. 31, 2016 $ 517 $ 43,762 $ 32,014,629   $ (3,419,715) $ (32,909,837) $ (4,270,644)
Ending Balance, Shares at Dec. 31, 2016 517,359 43,761,825     1,179,212